首页> 外文期刊>Biological & pharmaceutical bulletin >Inhibition of Tumor Cell Invasion and Matrix Degradation by Aminopeptidase Inhibitors
【24h】

Inhibition of Tumor Cell Invasion and Matrix Degradation by Aminopeptidase Inhibitors

机译:氨基肽酶抑制剂抑制肿瘤细胞侵袭和基质降解

获取原文
获取原文并翻译 | 示例
       

摘要

We investigated the effects of several types of aminopeptidase inhibitors on tumor cell-associated aminopeptidase activity and invasion. The aminopeptidase expressed by the human metastatic HT1080 fibrosarcoma cells was effectively suppressed by actinonin A, bestatin, leuhistin and matlystatin A, which are capable of inhibiting the purified aminopeptidase N, but not by arphamenine B specific for aminopeptidase B. The aminopeptidase N inhibitors inhibited HT1080 cells from degrading the subendothelial matrix and from invading into Matrigel in parallel with their aminopeptidase inhibitory activities. Matlystatin A, with multiple inhibitory activity against both aminopeptidase N and matrix metalloproteinases (MMP), was the most effective inhibitor of invasion. However, leuhistin and bestatin, without MMP inhibitory activity, also exhibited significant inhibition of invasion. The results suggest that aminopeptidase N plays a crucial role in the degradation and invasion of extracellular matrices by fibrosarcoma cells and that aminopeptidase inhibitors may be useful for preventing the spread of malignant tumors.
机译:我们调查了几种类型的氨肽酶抑制剂对肿瘤细胞相关的氨肽酶活性和侵袭的影响。人转移性HT1080纤维肉瘤细胞表达的氨肽酶可被肌动蛋白A,贝司他汀,亮氨酸和马来他汀A有效抑制,它们能够抑制纯化的氨肽酶N,但对特定于氨肽酶B的arphamenine B则无抑制作用。氨肽酶N抑制剂可抑制HT1080细胞降解内皮下基质,并与氨基肽酶抑制活性平行地侵入基质胶。 Matlystatin A对氨基肽酶N和基质金属蛋白酶(MMP)均具有多种抑制活性,是最有效的侵袭抑制剂。但是,没有MMP抑制活性的亮氨酸和Bestatin也具有显着的侵袭抑制作用。结果表明,氨基肽酶N在纤维肉瘤细胞对细胞外基质的降解和侵袭中起关键作用,并且氨基肽酶抑制剂可用于预防恶性肿瘤的扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号